The PRAC is recommending that in addition to the current educational material, patients and healthcare professionals in the EU should be given an acknowledgment form that will be used to confirm that doctors have discussed the risk with their patients, and that the patients understand the importance of monitoring and checking for signs of liver damage.
These recommendations, which strengthen provisional measures introduced in July 2017, will now be sent to the CHMP, which will adopt the Agency’s final opinion.